Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients (kffhealthnews.org)

submitted 11 months ago by [email protected] to c/[email protected]

0 comments fedilink hide all child comments

Racial disparities in drug trials, and disparities in overall medical care, among other factors, make the recently-approved Alzheimer's break-through drug lecanemab less likely to benefit African Americans.

no comments (yet)

sorted by: hot top controversial new old

there doesn't seem to be anything here

this post was submitted on 27 Jul 2023

1 points (100.0% liked)

Neurodegenative Disease Support

1 readers

1 users here now

This community is a gathering place for all those affected by neurodegenerative diseases. Patients, family, friends and caregivers are welcome. Share info, ask questions, or vent about your day. Whatever you'd like to talk about, we're here to listen.

COMMUNITY RULES

We follow the Mastodon Code of Conduct in this community.

Please be kind and supportive as you interact with others.

Do not ask for or offer medical advice. This is a community for support and encouragement only.

PARTNERED COMMUNITIES

founded 1 year ago

MODERATORS

[email protected]